Background: Progression to combined post-and pre-capillary pulmonary hypertension (PH) provides prognostic information in human patients with post-capillary PH. Pulmonary vascular resistance estimated by echocardiography (PVRecho) is useful for the stratification of dogs with myxomatous mitral valve disease (MMVD) and detectable tricuspid regurgitation. Objectives: To evaluate the prognostic value of PVRecho in dogs with MMVD. Animals: Fifty-four dogs with MMVD and detectable tricuspid regurgitation. Methods: Prospective cohort study. All dogs underwent echocardiography. The PVRecho was calculated based on tricuspid regurgitation and the velocity-time integral of the pulmonary artery flow. To evaluate the influence of echocardiographic variables on cardiac-related deaths, Cox proportional hazard analysis was performed. Additionally, Kaplan-Meier curves classified by PVRecho tertiles were made and compared using log-rank tests to evaluate the influence of PVRecho on all-cause mortality and cardiac-related death. Results: The median follow-up time was 579 days. Forty-one dogs with MMVD (PH severity [number]: no or mild, 21/33; moderate, 11/11; severe, 9/10) died during the study. In the multivariable Cox proportional hazard analysis adjusted for age, sildenafil administration, and American College of Veterinary Internal Medicine stage of MMVD, left atrial to aortic diameter ratio and PVRecho remained significant (adjusted hazard ratio [95% confidence interval]: 1.2 [1.1-1.3] and 2.1 [1.6-3.0], respectively). Higher PVRecho showed a significant association with lower survival rates. Abbreviations: 3seg, only right ventricular free wall analysis; 6seg, global right ventricular analysis; AUC, area under the curve; CI, confidence interval; E, early-diastolic transmitral flow velocity; E/A, early-diastolic to late-diastolic transmitral flow velocity ratio; e', tissue Doppler imaging-derived peak early-diastolic myocardial velocity of the septal mitral annulus; HR, hazard ratio; LA/Ao, left atrial to aortic diameter ratio; LVIDDN, end-diastolic left ventricular internal diameter normalized by body weight; LVIDSN, end-systolic left ventricular internal diameter normalized by body weight; MMVD, myxomatous mitral valve disease; PH, pulmonary hypertension; RHF, right heart failure; ROC, receiver operating characteristic; RV FACn, RV fractional area change normalized by body weight; RV s', tissue Doppler imaging-derived peak systolic myocardial velocity of the lateral tricuspid annulus; RV, right ventricular; RVEDA index, end-diastolic RV area normalized by body weight; RVESA index, end-systolic RV area normalized by body weight; RVIDd index, end-diastolic RV internal dimension normalized by body weight; RV-SL, RV longitudinal strain; RV-SrL, RV longitudinal strain rate; TAPSEn, tricuspid annular plane systolic excursion normalized by body weight; TR, tricuspid regurgitation.